pubmed-article:19273451 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C1709060 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C1619966 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
pubmed-article:19273451 | lifeskim:mentions | umls-concept:C1706907 | lld:lifeskim |
pubmed-article:19273451 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:19273451 | pubmed:dateCreated | 2009-4-3 | lld:pubmed |
pubmed-article:19273451 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:abstractText | To evaluate the safety and efficacy of abatacept plus methotrexate (MTX) over 5 years in patients with rheumatoid arthritis. | lld:pubmed |
pubmed-article:19273451 | pubmed:language | eng | lld:pubmed |
pubmed-article:19273451 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19273451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19273451 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19273451 | pubmed:month | Apr | lld:pubmed |
pubmed-article:19273451 | pubmed:issn | 0315-162X | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:ArandaRichard... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:EmeryPaulP | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:DougadosMaxim... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:WesthovensRen... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:MorelandLarry... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:RussellAnthon... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:BeckerJean-Cl... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:KremerJoel... | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:LiTracyT | lld:pubmed |
pubmed-article:19273451 | pubmed:author | pubmed-author:QiKeqinK | lld:pubmed |
pubmed-article:19273451 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19273451 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:19273451 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19273451 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19273451 | pubmed:pagination | 736-42 | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:meshHeading | pubmed-meshheading:19273451... | lld:pubmed |
pubmed-article:19273451 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19273451 | pubmed:articleTitle | Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study. | lld:pubmed |
pubmed-article:19273451 | pubmed:affiliation | Department of Rheumatology, KU Leuven, Herestraat 49, B 3000 Leuven, Belgium. rene.westhovens@uz.kuleuven.ac.be | lld:pubmed |
pubmed-article:19273451 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19273451 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19273451 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19273451 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273451 | lld:pubmed |